LCM
BMY icon

Logan Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Logan Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Buy
+19,447
New +$1.13M 0.05% 202

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Logan Capital Management's BMY Position: Q1 2026 in Review

Logan Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 33,256 shares — an estimated $1.94M sold.

Logan Capital Management first reported a position in BMY in Q2 2013 and held it in 51 quarters. The position peaked at $3.67M in Q4 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Logan Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Logan Capital Management sold 33,256 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.94M.
  • Logan Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 51 quarters.
  • Logan Capital Management's Bristol-Myers Squibb position peaked at $3.67M in Q4 2022.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.